 | • レポートコード：MRC2303E071 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、226ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：化学 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社発行の当調査レポートでは、2021年に8,221.43百万ドルであった世界のヒアルロン酸市場規模が、2022年に8,989.12百万ドルに達し、2027年には14,183.43百万ドルまで年平均9.51%成長すると予測しています。当レポートは、ヒアルロン酸の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、グレード別（化粧品用、食品用、医療用）分析、製剤別（HA、HA+リドカイン）分析、用途別（審美、化粧品、ダイエットサプリメント、眼科、その他）分析、流通別（病院、オンライン薬局、小売薬局、専門クリニック）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でまとめております。なお、当書には、Abbvie Inc.、Anika Therapeutics, Inc.、Bausch & Lomb Incorporated、Bioiberica S.A.U.、Bloomage BioTechnology Corporation Limited、Contipro a.s.、Evonik Industries AG、Ferring Pharmaceuticals, Inc.、Fidia Farmaceutici S.p.A.、Galderma S.A.、HTL Biotechnology、Kewpie Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のヒアルロン酸市場規模：グレード別 - 化粧品用ヒアルロン酸の市場規模 - 食品用ヒアルロン酸の市場規模 - 医療用ヒアルロン酸の市場規模 ・世界のヒアルロン酸市場規模：製剤別 - HAの市場規模 - HA+リドカインの市場規模 ・世界のヒアルロン酸市場規模：用途別 - 審美における市場規模 - 化粧品における市場規模 - ダイエットサプリメントにおける市場規模 - 眼科における市場規模 - その他用途における市場規模 ・世界のヒアルロン酸市場規模：流通別 - 病院の市場規模 - オンライン薬局の市場規模 - 小売薬局の市場規模 - 専門クリニックの市場規模 ・世界のヒアルロン酸市場規模：地域別 - 南北アメリカのヒアルロン酸市場規模 アメリカのヒアルロン酸市場規模 カナダのヒアルロン酸市場規模 ブラジルのヒアルロン酸市場規模 ... - アジア太平洋のヒアルロン酸市場規模 日本のヒアルロン酸市場規模 中国のヒアルロン酸市場規模 インドのヒアルロン酸市場規模 韓国のヒアルロン酸市場規模 台湾のヒアルロン酸市場規模 ... - ヨーロッパ/中東/アフリカのヒアルロン酸市場規模 イギリスのヒアルロン酸市場規模 ドイツのヒアルロン酸市場規模 インドのヒアルロン酸市場規模 フランスのヒアルロン酸市場規模 ロシアのヒアルロン酸市場規模 ... - その他地域のヒアルロン酸市場規模 ・競争状況 ・企業情報 |
The Global Hyaluronic Acid Market size was estimated at USD 8,221.43 million in 2021 and expected to reach USD 8,989.12 million in 2022, and is projected to grow at a CAGR 9.51% to reach USD 14,183.43 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Hyaluronic Acid to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Grade, the market was studied across Cosmetic Grade, Food Grade, and Medical Grade.
Based on Formulation, the market was studied across HA and HA + Lidocaine.
Based on Application, the market was studied across Aesthetics, Cosmetics, Dietary Supplement, Opthalmology, Osteoarthristis, and Pharmaceutical API.
Based on Distribution, the market was studied across Hospitals, Online Pharmacies, Retail Pharmacies, and Specialty Clinics.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Connecticut, Florida, Illinois, Maryland, Minnesota, New Jersey, New York, Ohio, Pennsylvania, Texas, and Washington. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Hyaluronic Acid market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hyaluronic Acid Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hyaluronic Acid Market, including Abbvie Inc., Anika Therapeutics, Inc., Bausch & Lomb Incorporated, Bioiberica S.A.U., Bloomage BioTechnology Corporation Limited, Contipro a.s., Evonik Industries AG, Ferring Pharmaceuticals, Inc., Fidia Farmaceutici S.p.A., Galderma S.A., HTL Biotechnology, Kewpie Corporation, Kikkoman Biochemifa Company, LG Chem Ltd., Lifecore Biomedical, LLC, Maruha Nichiro Corporation, Sanofi S.A., Seikagaku Corporation, Shiseido Company, Limited, Smith & Nephew PLC, and Zimmer Biomet.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Hyaluronic Acid Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hyaluronic Acid Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hyaluronic Acid Market?
4. What is the competitive strategic window for opportunities in the Global Hyaluronic Acid Market?
5. What are the technology trends and regulatory frameworks in the Global Hyaluronic Acid Market?
6. What is the market share of the leading vendors in the Global Hyaluronic Acid Market?
7. What modes and strategic moves are considered suitable for entering the Global Hyaluronic Acid Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Adoption of Non-surgical Cosmetic Procedures
5.1.1.2. Increasing Role of Hyaluronic Acid as Humectant in Skin Care Products
5.1.1.3. Growing Demand for Viscosupplementation for Osteoarthritis Treatment
5.1.2. Restraints
5.1.2.1. Increasing Concerns Regarding the Efficacy of Viscosupplementation Products
5.1.3. Opportunities
5.1.3.1. Focus Efforts Towards Hyaluronic Acid Research
5.1.3.2. Creating New Applications Based On HA Functionalization
5.1.4. Challenges
5.1.4.1. Risk of side effects of hyaluronic acid
5.2. Cumulative Impact of COVID-19
6. Hyaluronic Acid Market, by Grade
6.1. Introduction
6.2. Cosmetic Grade
6.3. Food Grade
6.4. Medical Grade
7. Hyaluronic Acid Market, by Formulation
7.1. Introduction
7.2. HA
7.3. HA + Lidocaine
8. Hyaluronic Acid Market, by Application
8.1. Introduction
8.2. Aesthetics
8.3. Cosmetics
8.4. Dietary Supplement
8.5. Opthalmology
8.6. Osteoarthristis
8.7. Pharmaceutical API
9. Hyaluronic Acid Market, by Distribution
9.1. Introduction
9.2. Hospitals
9.3. Online Pharmacies
9.4. Retail Pharmacies
9.5. Specialty Clinics
10. Americas Hyaluronic Acid Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Hyaluronic Acid Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Hyaluronic Acid Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbvie Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Anika Therapeutics, Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Bausch & Lomb Incorporated
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Bioiberica S.A.U.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Bloomage BioTechnology Corporation Limited
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Contipro a.s.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Evonik Industries AG
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Ferring Pharmaceuticals, Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Fidia Farmaceutici S.p.A.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Galderma S.A.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. HTL Biotechnology
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Kewpie Corporation
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Kikkoman Biochemifa Company
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. LG Chem Ltd.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Lifecore Biomedical, LLC
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Maruha Nichiro Corporation
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Sanofi S.A.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Seikagaku Corporation
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Shiseido Company, Limited
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Smith & Nephew PLC
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Zimmer Biomet
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing